AR070573A1 - Derivados de 5,6 - bisaril -2- piridina - carboxamida, su preparacion, un medicamento y una composicion farmaceutica en base al compuesto, y la utilizacion del compuesto para la preparacion de un medicamento - Google Patents
Derivados de 5,6 - bisaril -2- piridina - carboxamida, su preparacion, un medicamento y una composicion farmaceutica en base al compuesto, y la utilizacion del compuesto para la preparacion de un medicamentoInfo
- Publication number
- AR070573A1 AR070573A1 ARP090100392A ARP090100392A AR070573A1 AR 070573 A1 AR070573 A1 AR 070573A1 AR P090100392 A ARP090100392 A AR P090100392A AR P090100392 A ARP090100392 A AR P090100392A AR 070573 A1 AR070573 A1 AR 070573A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- representing
- alkoxy
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos tienen la aplicacion en terapéutica como antagonistas de los receptores de urotensina 2 para el tratamiento de la insuficiencia cardiaca, infarto de miocardio, enfermedades coronarias, hipertension, insuficiencia renal, diabetes inflamacion vascular y enfermedades neurodegenerativas. Reivindicacion 1: Compuesto que responde a la formula (1) en la que: X e Y representan independientemente el uno del otro un átomo de nitrogeno o un eslabon -CR4-, en el que R4 representa un átomo de hidrogeno o un grupo alquilo C1-4 o alcoxi; A representa un grupo arilo o heteroarilo, estando dichos grupos arilo o heteroarilo sustituidos opcionalmente con uno o varios grupos elegidos entre un átomo de un grupo hidroxi, alquilo C1-4, cicloalquiloC3-5, alcoxi C1-4 opcionalmente con un grupo alcoxi C1-4, halogenoalquilo, halogenoalcoxi, un grupo nitrilo W representa un átomo de halogeno o un grupo halogenoalquilo; Z representa un grupo alquileno C1-4 sustituido opcionalmente con uno o varios grupos elegidos entre un átomo de halogeno y los grupos alquilo C1-4, hidroxi y alcoxi C1-4; B representa un grupo -NR4R5, en el que R4 y R5 representan independientemente el uno del otro un grupo alquilo C1-4 R1 y R2 representan: bien, R1 representa un átomo de hidrogeno y R2 representa un grupo alquilo C1-4; bien R1 y R2 forman juntos, con el átomo de carbono al que están unidos, un sistema mono o policíclico elegido entre un grupo cicloalquilo C3-8, un grupo bicíclico con enlaces puente o un grupo tetracíclico con enlaces puente, pudiendo estar dicho sistema sustituido con uno o varios grupos hidroxi; R3 representa: bien un grupo C(O)R5 con R5 que representa un grupo alcoxi C1-4 sustituido opcionalmente con un grupo alcoxi C1-4 o un grupo NR6R7 con R6 y R7 independientemente el uno del otro que representan un átomo de hidrogeno, un grupo alquilo C1-4, cicloalquilo C3-5, alquil C1-4 sulfonilo, halogenoalquilo, bien un grupo -CH2XR8 con: X que representa un átomo de oxígeno y R8 que representa un átomo de hidrogeno o un grupo alquilo C1-4, o X que representa un grupo NH y R8 que representa un grupo alquil C1-4 carbonilo, alquil C1-4 carboxilo o alquil C1-4 sulfonilo, bien un grupo nitrilo(CN) p representa un numero entero igual a 0 o 1, en el estado de base o de sal de adicion a un ácido o a una base, así como sus enantiomeros y diastereoisomeros, incluidas sus mezclas racémicas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0800651A FR2927330B1 (fr) | 2008-02-07 | 2008-02-07 | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070573A1 true AR070573A1 (es) | 2010-04-21 |
Family
ID=39434382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090100392A AR070573A1 (es) | 2008-02-07 | 2009-02-05 | Derivados de 5,6 - bisaril -2- piridina - carboxamida, su preparacion, un medicamento y una composicion farmaceutica en base al compuesto, y la utilizacion del compuesto para la preparacion de un medicamento |
Country Status (22)
Country | Link |
---|---|
US (2) | US8466292B2 (es) |
EP (1) | EP2238110B1 (es) |
JP (1) | JP2011511046A (es) |
KR (1) | KR20100116183A (es) |
CN (1) | CN101981008B (es) |
AR (1) | AR070573A1 (es) |
AT (1) | ATE530527T1 (es) |
AU (1) | AU2009227091B2 (es) |
BR (1) | BRPI0907719A2 (es) |
CA (1) | CA2715096A1 (es) |
CY (1) | CY1112670T1 (es) |
DK (1) | DK2238110T3 (es) |
ES (1) | ES2375339T3 (es) |
FR (1) | FR2927330B1 (es) |
HR (1) | HRP20120069T1 (es) |
IL (1) | IL207356A0 (es) |
MX (1) | MX2010008713A (es) |
PL (1) | PL2238110T3 (es) |
PT (1) | PT2238110E (es) |
RU (1) | RU2497808C2 (es) |
SI (1) | SI2238110T1 (es) |
WO (1) | WO2009115665A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
SG11201502527UA (en) * | 2012-10-05 | 2015-04-29 | Rigel Pharmaceuticals Inc | Gdf-8 inhibitors |
TWI736517B (zh) | 2013-12-24 | 2021-08-21 | 美商必治妥美雅史谷比公司 | 作為抗癌劑之新穎三環化合物 |
PT3778595T (pt) | 2015-02-27 | 2021-11-09 | Calcimedica Inc | Tratamento de pancreatite |
WO2016183114A1 (en) | 2015-05-11 | 2016-11-17 | Bristol-Myers Squibb Company | Tricyclic compounds as anticancer agents |
WO2017019757A1 (en) | 2015-07-28 | 2017-02-02 | Bristol-Myers Squibb Company | Tgf beta receptor antagonists |
DK3331525T3 (da) * | 2015-08-07 | 2020-12-14 | Calcimedica Inc | Anvendelse af CRAC-kanal-inhibitorer til behandling af slagtilfælde og traumatisk hjerneskade |
WO2017035118A1 (en) | 2015-08-25 | 2017-03-02 | Bristol-Myers Squibb Company | Tgf beta receptor antagonists |
CN108368174B (zh) | 2015-11-23 | 2023-04-14 | 戊瑞治疗有限公司 | 用于癌症治疗的单独fgfr2抑制剂或与免疫刺激剂的组合 |
WO2017152085A1 (en) | 2016-03-04 | 2017-09-08 | Bristol-Myers Squibb Company | Combination therapy with anti-cd73 antibodies |
CA3135802A1 (en) | 2019-04-05 | 2020-10-08 | Kymera Therapeutics, Inc. | Stat degraders and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0104332D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
WO2004073634A2 (en) * | 2003-02-20 | 2004-09-02 | Encysive Pharmaceuticals Inc. | Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
AU2004218456A1 (en) * | 2003-02-28 | 2004-09-16 | Encysive Pharmaceuticals Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists. |
FR2856684B1 (fr) * | 2003-06-26 | 2008-04-11 | Sanofi Synthelabo | Derives de diphenylpyridine, leur preparation et leur application en therapeutique |
FR2904827B1 (fr) * | 2006-08-11 | 2008-09-19 | Sanofi Aventis Sa | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii |
-
2008
- 2008-02-07 FR FR0800651A patent/FR2927330B1/fr not_active Expired - Fee Related
-
2009
- 2009-02-05 SI SI200930139T patent/SI2238110T1/sl unknown
- 2009-02-05 ES ES09721603T patent/ES2375339T3/es active Active
- 2009-02-05 PL PL09721603T patent/PL2238110T3/pl unknown
- 2009-02-05 KR KR1020107017495A patent/KR20100116183A/ko not_active Application Discontinuation
- 2009-02-05 AR ARP090100392A patent/AR070573A1/es not_active Application Discontinuation
- 2009-02-05 CN CN2009801112181A patent/CN101981008B/zh not_active Expired - Fee Related
- 2009-02-05 RU RU2010137115/04A patent/RU2497808C2/ru not_active IP Right Cessation
- 2009-02-05 DK DK09721603.0T patent/DK2238110T3/da active
- 2009-02-05 JP JP2010545523A patent/JP2011511046A/ja active Pending
- 2009-02-05 AT AT09721603T patent/ATE530527T1/de active
- 2009-02-05 BR BRPI0907719-7A patent/BRPI0907719A2/pt not_active IP Right Cessation
- 2009-02-05 EP EP09721603A patent/EP2238110B1/fr active Active
- 2009-02-05 AU AU2009227091A patent/AU2009227091B2/en not_active Ceased
- 2009-02-05 WO PCT/FR2009/000128 patent/WO2009115665A1/fr active Application Filing
- 2009-02-05 MX MX2010008713A patent/MX2010008713A/es active IP Right Grant
- 2009-02-05 PT PT09721603T patent/PT2238110E/pt unknown
- 2009-02-05 CA CA2715096A patent/CA2715096A1/fr not_active Abandoned
-
2010
- 2010-08-02 IL IL207356A patent/IL207356A0/en unknown
- 2010-08-06 US US12/851,941 patent/US8466292B2/en not_active Expired - Fee Related
-
2012
- 2012-01-23 HR HR20120069T patent/HRP20120069T1/hr unknown
- 2012-01-25 CY CY20121100089T patent/CY1112670T1/el unknown
-
2013
- 2013-05-15 US US13/894,872 patent/US8653276B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2009115665A1 (fr) | 2009-09-24 |
RU2010137115A (ru) | 2012-03-20 |
US20110009426A1 (en) | 2011-01-13 |
PL2238110T3 (pl) | 2012-03-30 |
CN101981008B (zh) | 2013-07-31 |
AU2009227091B2 (en) | 2013-05-23 |
JP2011511046A (ja) | 2011-04-07 |
FR2927330A1 (fr) | 2009-08-14 |
IL207356A0 (en) | 2010-12-30 |
MX2010008713A (es) | 2010-09-09 |
BRPI0907719A2 (pt) | 2015-07-14 |
CY1112670T1 (el) | 2016-02-10 |
HRP20120069T1 (hr) | 2012-02-29 |
PT2238110E (pt) | 2012-01-02 |
US20130252974A1 (en) | 2013-09-26 |
AU2009227091A1 (en) | 2009-09-24 |
SI2238110T1 (sl) | 2012-02-29 |
US8653276B2 (en) | 2014-02-18 |
EP2238110B1 (fr) | 2011-10-26 |
DK2238110T3 (da) | 2012-02-20 |
US8466292B2 (en) | 2013-06-18 |
CN101981008A (zh) | 2011-02-23 |
RU2497808C2 (ru) | 2013-11-10 |
FR2927330B1 (fr) | 2010-02-19 |
ES2375339T3 (es) | 2012-02-29 |
ATE530527T1 (de) | 2011-11-15 |
CA2715096A1 (fr) | 2009-09-24 |
EP2238110A1 (fr) | 2010-10-13 |
KR20100116183A (ko) | 2010-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070573A1 (es) | Derivados de 5,6 - bisaril -2- piridina - carboxamida, su preparacion, un medicamento y una composicion farmaceutica en base al compuesto, y la utilizacion del compuesto para la preparacion de un medicamento | |
CY1118973T1 (el) | Παραγωγα αμιδιου βενζοϊμιδαζολο-καρβοξυλικου οξεος για τη θεραπεια μεταβολικων ή καρδιαγγειακων νοσηματων | |
CL2009000127A1 (es) | Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1. | |
AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
ECSP088871A (es) | Derivados de triazolopirazina | |
SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
UY30183A1 (es) | Derivados de quinolina | |
AR053092A1 (es) | Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis | |
AR077999A1 (es) | Antagonistas de pirimidin y triazin-hepcidina | |
AR060429A1 (es) | Compuestos de tioxantina y composicion farmaceutica en base a dichos compuestos | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
AR058073A1 (es) | Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos | |
ECSP12011838A (es) | Derivados de la cromenona con actividad anti-tumoral | |
AR062409A1 (es) | Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto | |
UY29469A1 (es) | Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos. | |
GT200600165A (es) | Derivados dihidrobenzofuranos y usos de los mismos | |
PA8795301A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
AR086100A1 (es) | Compuestos de cromenona y composiciones farmaceuticas que los contienen | |
AR045155A1 (es) | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
CR9722A (es) | Derivados de benzilpiperazina y su uso medico | |
EA201201662A1 (ru) | Дизамещенные тетрагидрофуранильные соединения в качестве антагонистов брадикининового рецептора в1 | |
AR086803A1 (es) | Derivados de oxazetidinas, composiciones farmaceuticas y cosmeticas que los contienen y uso de los mismos para tratar enfermedades dermatologicas fundamentalmente, y del aparato respiratorio, digestivo y cardiovascular, entre otras | |
AR055367A1 (es) | Piperazinas biciclicas como antagonistas de receptores de glutamato metabotropicos | |
AR079543A1 (es) | Derivados de amino-heteroarilo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |